Fundraising Fox

Biotech Startups

10,099 companies tagged Biotech, with their investors and founders.

Turtle Health

0 investors

TVAX Biomedical

TVAX Biomedical develops TVAX Immunotherapy, a personalized adoptive T cell therapy for cancer patients that combines a vaccination step using a patient's own cancer cells with activated killer T cell treatment. Its lead candidate, TVI-Brain-1, is in a phase 2b clinical trial for glioblastoma (brain cancer) and has received FDA Fast Track Designation.

0 investors

Twister Biotech

0 investors

Two Pore Guys

0 investors

Twoxar

0 investors

Tygrus

Tygrus is a life science research, development, and licensing company that develops safer chemical alternatives based on its patented Tydronium acid, used to replace hazardous disinfectants, toxic preservatives, and other harmful chemicals. Through wholly owned subsidiaries, it licenses this technology across agriculture (Aqueus/Growthful), respiratory therapeutics (Miracus/Tydracin), and personal care (Wonderus), and is headquartered in Troy, Michigan.

0 investors

Tyme Technologies

0 investors

U.S Stem Cell

0 investors

U1 Bio

0 investors

UberSeq

0 investors

Ubivac

UbiVac is a clinical-stage cancer immunotherapy and target-discovery company developing off-the-shelf combination vaccines, including its lead agent DPV-001, based on "Dark Genome"-derived non-mutated shared cancer neoantigens. Its therapies are being tested in first-in-human trials for cancers such as head and neck squamous cell carcinoma and non-small cell lung cancer, with the company also applying machine learning to discover novel cancer targets.

0 investors

UCB S.A

0 investors

UCHU Biosensors

0 investors

Ufovax

0 investors

Uluru

0 investors

Unicycive Therapeutics

0 investors

Uniform Bio

0 investors

Unleash Immuno Oncolytics

0 investors

Unravel Biosciences

0 investors

Urica Therapeutics

0 investors

Urigen Pharmaceuticals

Urigen Pharmaceuticals develops treatments for interstitial cystitis and related bladder conditions. The company is led by researchers and executives with extensive experience in pharmaceutical development and commercialization.

0 investors

Urology Diagnostics

0 investors

Uromedica

Uromedica is a medical device company that develops long-term implantable adjustable balloon therapy to treat male and female stress urinary incontinence, marketed as ProACT for men and ACT for women. Its urologic implants are used by patients and partnered physicians, with availability in Europe, Canada, and Australia while the female ACT system remains investigational in the US.

0 investors

US Medical Innovations

US Medical Innovations develops the Canady Helios Cold Plasma treatment, a medical technology used intraoperatively by surgeons and surgical oncologists during cancer procedures. The company's product is applied in clinical settings such as tumor surgery and orthopaedic care.

0 investors

Other sectors & tags